Raymond James Financial Inc Adma Biologics, Inc. Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 1,251,796 shares of ADMA stock, worth $19.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,251,796
Previous 1,522,045
17.76%
Holding current value
$19.5 Million
Previous $27.7 Million
33.79%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ADMA
# of Institutions
401Shares Held
205MCall Options Held
3.08MPut Options Held
1.9M-
Vanguard Group Inc Valley Forge, PA21MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA13.6MShares$211 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.5MShares$195 Million0.03% of portfolio
-
Sachem Head Capital Management LP New York, NY8.96MShares$139 Million5.63% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.06B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...